<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38135813</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2568</ISSN><JournalIssue CitedMedium="Internet"><Volume>69</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Digestive diseases and sciences</Title><ISOAbbreviation>Dig Dis Sci</ISOAbbreviation></Journal><ArticleTitle>Gastrointestinal Manifestations and Their Association with Neurologic and Sleep Problems in Long COVID-19 Minority Patients: A Prospective Follow-Up Study.</ArticleTitle><Pagination><StartPage>562</StartPage><EndPage>569</EndPage><MedlinePgn>562-569</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10620-023-08176-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long-COVID is a condition post SARS-CoV-2 infection with persistent or recurring symptoms affecting multiple organs, and may involve viral persistence, changes to the microbiome, coagulopathies, and alterations to neuro-immune interactions. These factors can disrupt the Gut-Brain Axis, which is a complex system involving bidirectional communication between the central nervous system and the gastrointestinal (GI) system. As a result of these disruptions, individuals with long-COVID may develop post-infectious functional GI disorders, which can cause a range of symptoms affecting the digestive system.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To understand frequency of GI manifestations of Long-COVID and to determine association with sleep or neurological symptoms in a predominantly minority population.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included patients with positive SARS-CoV-2 PCR (n&#x2009;=&#x2009;747) who were hospitalized from Feb. 2020 to May 2021 at Howard University Hospital and followed between 6 and 12&#xa0;months from discharge. GI, sleep, and neurological symptoms (via the Montreal Cognitive Assessment (MoCA) scoring system) were assessed using a standardized questionnaire. Linear regression analysis, &#x3c7;<sup>2</sup> and Fisher's exact test were utilized to determine the statistical significance of correlations of GI/Neuro/COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of patients was 58, with 51.6% females and a predominant African American ethnicity (73.6%, n&#x2009;=&#x2009;550). A total of 108 patients died during their initial hospital stay, with the remaining 639 patients followed-up. Three hundred fifty (350) patients responded to the questionnaire (57 patients died during the follow-up period). Overall, 39 (13.3%) patients reported GI-related symptoms, out of which 19 (6.4%) had persistent symptoms and 20 (6.8%) developed new onset GI symptoms. Nausea and vomiting were the most common 24/39 (61.5%), followed by abdominal pain 7/39 (18%), diarrhea 5/39 (12.8%), and others 3/39 (7.6%). Patients who presented with vomiting during acute SARS-CoV-2 infection were more likely to have Long-COVID GI manifestations (P&#x2009;=&#x2009;0.023). Use of ACE inhibitors, abnormal lymphocyte count and elevated ferritin are other variables that showed significant associations with Long-COVID GI manifestations (P&#x2009;=&#x2009;0.03, 0.006 and 0.03, respectively). During follow-up, a total of 28 (9.5%) patients reported difficulty with sleep and 79 (27%) patients had abnormal MoCA assessment. With further analysis, there was a trend between presentation of GI symptoms on admission with abnormal MoCA assessment, and an association between abnormal LFTs and history of liver disease during hospitalization with subsequent sleep problems. Baseline characteristics, clinical comorbidities, other laboratory values, hospital length of stay, mechanical ventilation, medications during hospitalization, re-admission and Flu or COVID-19 vaccination have not shown any association with Long-COVID GI symptoms in our cohort.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Dyspeptic symptoms were common GI manifestations in the acute and post COVID periods. GI symptoms, abnormal LFTs and a history of liver disease during the acute infectious phase associates with abnormal MoCA and sleep problems during follow-up. Further large population studies are needed to determine if COVID-19 leads to a GI symptoms-associated Long-COVID phenotypes and other symptoms through the Gut-Brain-Axis.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashktorab</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-4048-4666</Identifier><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA. hashktorab@howard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard University College of Medicine, 2041 Georgia Avenue, N.W., Washington, DC, 20060, USA. hashktorab@howard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Challa</LastName><ForeName>Suryanarayana Reddy</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Gagan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanduri</LastName><ForeName>Sumant</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Malika</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martirosyan</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Howard University College of Medicine, 2041 Georgia Avenue, N.W., Washington, DC, 20060, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitsell</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Howard University College of Medicine, 2041 Georgia Avenue, N.W., Washington, DC, 20060, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chirumamilla</LastName><ForeName>Lakshmi G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shayegh</LastName><ForeName>Nader</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Kyra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Tori</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogwo</LastName><ForeName>Valarie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Engineering and Technology, American University of the Middle East, Egaila, Kuwait.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology &amp; Hepatology, Department of Medicine and Moores Cancer Center, UC San Diego, San Diego, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kolawole</LastName><ForeName>Oluwapelumi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Littleton</LastName><ForeName>Megan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nair</LastName><ForeName>Vaisakh</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byer</LastName><ForeName>Danae</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawodu</LastName><ForeName>Dideolu O</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lexima</LastName><ForeName>Patrice</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rashid</LastName><ForeName>Mudasir</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deverapalli</LastName><ForeName>Mrinalini</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atluri</LastName><ForeName>Swetha Mynedi</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nezamloo</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasrin</LastName><ForeName>Farjana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Rachel Ji-Aeh</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>GI Division, Department of Medicine, Cancer Center, Howard University Hospital, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherif</LastName><ForeName>Zaki</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biochemistry &amp; Molecular Biology, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oskrochi</LastName><ForeName>Gholamreza</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>College of Engineering and Technology, American University of the Middle East, Egaila, Kuwait.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carethers</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Gastroenterology &amp; Hepatology, Department of Medicine and Moores Cancer Center, UC San Diego, San Diego, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brim</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cancer Center, Howard University College of Medicine, Washington, DC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 CA258519</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dig Dis Sci</MedlineTA><NlmUniqueID>7902782</NlmUniqueID><ISSNLinking>0163-2116</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008107" MajorTopicYN="Y">Liver Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014839" MajorTopicYN="N">Vomiting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012893" MajorTopicYN="Y">Sleep Wake Disorders</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">African Americans</Keyword><Keyword MajorTopicYN="N">And Mini-MoCA</Keyword><Keyword MajorTopicYN="N">Gastrointestinal manifestations</Keyword><Keyword MajorTopicYN="N">Long-COVID</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Sleep problems</Keyword></KeywordList><CoiStatement><b>Conflict-of-interest statement:</b> The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38135813</ArticleId><ArticleId IdType="mid">NIHMS1983963</ArticleId><ArticleId IdType="pmc">PMC11070273</ArticleId><ArticleId IdType="doi">10.1007/s10620-023-08176-w</ArticleId><ArticleId IdType="pii">10.1007/s10620-023-08176-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation> 
 https://covid19.who.int/
</Citation></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6
October
2021, https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (2021, accessed 23 March 2022).</Citation></Reference><Reference><Citation>CDC. Long COVID or post-COVID conditions, https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html</Citation></Reference><Reference><Citation>  https://covid19.nih.gov/covid-19-topics/long-covid#:~:text=Long%20COVID%2C%20long%2Dhaul%20COVID,of%20a%20COVID%2D19%20diagnosis.</Citation></Reference><Reference><Citation>Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, Ng YY, Chu MY, Chung TWH, Tam AR, Yip CCY, Leung KH, Fung AY, Zhang RR, Lin Y, Cheng HM, Zhang AJX, To KKW, Chan KH, Yuen KY, Leung WK. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020. Jul;159(1):81&#x2013;95. doi: 10.1053/j.gastro.2020.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.065</ArticleId><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar-M P, Mishra S, Jha DK, Shukla J, Choudhury A, Mohindra R, Mandavdhare HS, Dutta U, Sharma V. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis. Hepatol Int. 2020. Sep;14(5):711&#x2013;722. doi: 10.1007/s12072-020-10071-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12072-020-10071-9</ArticleId><ArticleId IdType="pmc">PMC7335221</ArticleId><ArticleId IdType="pubmed">32623633</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizuorno A, Brim H, Ashktorab H. Gastrointestinal manifestations and SARS-CoV-2 infection. Curr Opin Pharmacol. 2021. Dec;61:114&#x2013;119. doi: 10.1016/j.coph.2021.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2021.09.005</ArticleId><ArticleId IdType="pmc">PMC8463306</ArticleId><ArticleId IdType="pubmed">34688995</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, Sharma V. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis. Therap Adv Gastroenterol. 2022. Aug 19;15:17562848221118403. doi: 10.1177/17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Cai G, Chen F, Christiani DC, Zhang Z, Wang M. Multiomics Evaluation of Gastrointestinal and Other Clinical Characteristics of COVID-19. Gastroenterology (2020) 158:2298&#x2013;2301.e2297. doi: 10.1053/j.gastro.2020.03.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.03.045</ArticleId><ArticleId IdType="pmc">PMC7270476</ArticleId><ArticleId IdType="pubmed">32234303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen HL, Chan MCW, et al.. Stability of SARS-CoV-2 in Different Environmental Conditions. Lancet Microbe (2020) 1:e10. doi: 10.1016/s2666-5247(20)30003-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2666-5247(20)30003-3</ArticleId><ArticleId IdType="pmc">PMC7214863</ArticleId><ArticleId IdType="pubmed">32835322</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Wu Z, Zhang M, Liu S, Zhou L, Yang C, Liu C. The Role of the Gastrointestinal System in Neuroinvasion by SARS-CoV-2. Front Neurosci. 2021. Jul 2;15:694446. doi: 10.3389/fnins.2021.694446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.694446</ArticleId><ArticleId IdType="pmc">PMC8283125</ArticleId><ArticleId IdType="pubmed">34276298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyun M, Baek Y &amp; Lee S Association between digestive symptoms and sleep disturbance: a cross-sectional community-based study. BMC Gastroenterol 19, 34 (2019). 10.1186/s12876-019-0945-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-019-0945-9</ArticleId><ArticleId IdType="pmc">PMC6381712</ArticleId><ArticleId IdType="pubmed">30782128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashktorab H, Pizuorno A, Adeleye F et al. Correction: Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans. BMC Infect Dis 22, 712 (2022). 10.1186/s12879-022-07699-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07699-3</ArticleId><ArticleId IdType="pmc">PMC9204073</ArticleId><ArticleId IdType="pubmed">35715729</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashktorab H, Folake A, Pizuorno A, Oskrochi G, Oppong-Twene P, Tamanna N, Mehdipour Dalivand M, Umeh LN, Moon ES, Kone AM, Banson A, Federman C, Ramos E, Awoyemi EO, Wonni BJ, Otto E, Maskalo G, Velez AO, Rankine S, Thrift C, Ekwunazu C, Scholes D, Chirumamilla LG, Ibrahim ME, Mitchell B, Ross J, Curtis J, Kim R, Gilliard C, Mathew J, Laiyemo A, Kibreab A, Lee E, Sherif Z, Shokrani B, Aduli F, Brim H. COVID-19 among African Americans and Hispanics: Does gastrointestinal symptoms impact the outcome? World J Clin Cases 2021; 9(28): 8374&#x2013;8387X. Carethers JM. Insights into disparities observed with COVID-19. J Intern Med 289:463&#x2013;473, 2021.Y. Ashktorab H, Pizuorno A, Adeleye F, Laiyemo AO, Dalivand MM, Aduli F, Sherif ZA, Oskrochi G, Angesom K, Oppong-Twene P, Challa SR, Okorie N, Moom ES, Romos E, Jones-Wonni B, Kone AM, Rankine S, Thrift C, Scholes D, Ekwunazu C, Banson A, Mitchell B, Maskalo G, Ross J, Curtis J, Kim R, Gilliard C, Ahuja G, Mathew J, Gavin W, Kara A, Hache-Marliere M, Paliodimos L, Mani VR, Kalabin A, Gayam VR, Garlapati PR, Miller J, Chirumamilla LG, Jackson F, Carethers JM, Kamangar F, Brim H. Symptomatic, Clinical and Biomarker Associations for Mortality in Hospitalized COVID-19 Patients Enriched for African Americans. BMC Infectious Diseases, 22:552, 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554449</ArticleId><ArticleId IdType="pubmed">34754847</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva F. A. F.da., Brito B. B. de., Santos, Marques HS., Silva J&#xfa;nior R. T. da., Carvalho L. S. de., Vieira ES., Oliveira MV., &amp; Melo F. F. de. (2020). COVID-19 gastrointestinal manifestations: a systematic review. Revista Da Sociedade Brasileira De Medicina Tropical, 53(Rev. Soc. Bras. Med. Trop., 2020 53). 10.1590/0037-8682-0714-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0714-2020</ArticleId><ArticleId IdType="pmc">PMC7723378</ArticleId><ArticleId IdType="pubmed">33263693</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff A, Kavanaugh M, Ramgobin D, McClafferty B, Aggarwal CS, Golamari R, Jain R. Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021. Summer;21(2):177&#x2013;180. doi: 10.31486/toj.20.0086.</Citation><ArticleIdList><ArticleId IdType="doi">10.31486/toj.20.0086</ArticleId><ArticleId IdType="pmc">PMC8238098</ArticleId><ArticleId IdType="pubmed">34239378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kariyawasam JC, Jayarajah U, Riza R, Abeysuriya V, Seneviratne SL. Gastrointestinal manifestations in COVID-19. Trans R Soc Trop Med Hyg. 2021. Dec 2;115(12):1362&#x2013;1388. doi: 10.1093/trstmh/trab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trab042</ArticleId><ArticleId IdType="pmc">PMC7989191</ArticleId><ArticleId IdType="pubmed">33728439</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Weibiaoa*,; Qi, Kaia b*; Ye Miaoc*; Zheng Lid; Liu Xinlianga; Hu Shenga; Zhang Wenxionga; Tang Wenjingb; Xu Jianjuna; Yu Donglianga; Wei Yipinga. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis. European Journal of Gastroenterology &amp; Hepatology 34(2):p 168&#x2013;176, February 2022. | DOI: 10.1097/MEG.0000000000002072</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000002072</ArticleId><ArticleId IdType="pubmed">33470700</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H, Mehandru S Gastrointestinal post-acute COVID-19 syndrome. Nat Rev Gastroenterol Hepatol 19, 345&#x2013;346 (2022). 10.1038/s41575-022-00611-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00611-z</ArticleId><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Tariq R, Jena A, Vesely EK, Singh S, Khanna S, Sharma V. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis. Therap Adv Gastroenterol. 2022. Aug 19;15:17562848221118403. doi: 10.1177/17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y &amp; Bowe B High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594, 259&#x2013;264 (2021). 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostanc&#x131;kl&#x131;o&#x11f;lu M Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2. Inflamm Bowel Dis. 2020. Jul 17;26(8):e89&#x2013;e91. doi: 10.1093/ibd/izaa131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ibd/izaa131</ArticleId><ArticleId IdType="pmc">PMC7313997</ArticleId><ArticleId IdType="pubmed">32440692</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakili K, Fathi M, Yaghoobpoor S, Sayehmiri F, Nazerian Y, Nazerian A, Mohamadkhani A, Khodabakhsh P, R&#xe9;us GZ, Hajibeygi R, Rezaei-Tavirani M. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature. Front Cell Infect Microbiol. 2022. Dec 22;12:983089. doi: 10.3389/fcimb.2022.983089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.983089</ArticleId><ArticleId IdType="pmc">PMC9815719</ArticleId><ArticleId IdType="pubmed">36619768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mekhael M, Lim CH, El Hajjar AH, Noujaim C, Pottle C, Makan N, Dagher L, Zhang Y, Chouman N, Li DL, Ayoub T, Marrouche N. Studying the Effect of Long COVID-19 Infection on Sleep Quality Using Wearable Health Devices: Observational Study. J Med Internet Res. 2022. Jul 5;24(7):e38000. doi: 10.2196/38000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/38000</ArticleId><ArticleId IdType="pmc">PMC9258734</ArticleId><ArticleId IdType="pubmed">35731968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H, Hegde S, LaFiura C, et al. COVID-19 illness in relation to sleep and burnout BMJ Nutrition, Prevention &amp; Health 2021;4:doi: 10.1136/bmjnph-2021-000228</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2021-000228</ArticleId><ArticleId IdType="pmc">PMC7995669</ArticleId><ArticleId IdType="pubmed">34308120</ArticleId></ArticleIdList></Reference><Reference><Citation> 
 https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html
.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>